Secondary Cancer Risk in Breast Cancer with and without Radiotherapy: The Observational Health Data Sciences and Informatics (OHDSI) Cohort Study [0.03%]
有与无放射治疗的乳腺癌继发癌症风险：OHDSI队列研究
Seok Kim,Dachung Boo,Sooyoung Yoo et al.
Seok Kim et al.
Purpose: Radiotherapy is used to reduce the risk of breast cancer recurrence after surgery, but it is a potential cause of secondary cancer. We validated the risk of secondary cancer in primary breast cancer who received ...
Programmed Death-Ligand 1 Expression Across Multiple Assays in Ovarian Cancer: A Comparative Analysis [0.03%]
卵巢癌中多种测定方法的程序性死亡配体-1表达情况：比较分析
Eun Bi Jang,Kyeong A So,Wook Youn Kim et al.
Eun Bi Jang et al.
Purpose: Ovarian cancer presents significant treatment challenges due to its aggressive nature and poor response to immune checkpoint inhibitors (ICIs). The lack of standardized programmed cell death-ligand 1 (PD-L1) assa...
Efficacy and Safety of Ifosfamide and Mesna in Metastatic Castration-Resistant Prostate Cancer after Taxane-Based Chemotherapy and Novel Hormonal Therapy Failure [0.03%]
多西他赛化疗及新型激素治疗失败后的晚期前列腺癌患者司莫司汀联合美司钠的疗效与安全性研究
Chang Gon Kim,Yeo Gyeong Ko,Jongjin Yoon et al.
Chang Gon Kim et al.
Purpose: Limited treatment options exist for patients with metastatic castration-resistant prostate cancer (mCRPC) after the failure of taxane-based chemotherapy and novel hormonal therapy. Here, we report the safety and ...
Radiation-Associated Heart Disease in Korean Women after Radiotherapy for Breast Cancer: Insights from the National Health Insurance Service Database [0.03%]
基于国民健康保险服务数据库的韩国乳腺癌放疗后女性放射相关性心脏病研究
Jun-Hyuk Lee,Jimin Park,Tae Hyung Kim
Jun-Hyuk Lee
Purpose: This study investigated the risk of radiation-associated heart disease (RAHD) in Korean women treated with radiotherapy (RT) for breast cancer (BC) using data from the National Health Insurance Service database. ...
Discrepancy between Genetically Predicted and Observed Alcohol Intake and Its Impact on Gastric Cancer Susceptibility [0.03%]
遗传预测的与观察到的饮酒量之间的差异及其对胃癌易感性的影响
Ga-Eun Yie,Cheol Min Shin,Kyungtaek Park et al.
Ga-Eun Yie et al.
Purpose: We aimed to investigate how genetic predisposition to drinking and gastric cancer (GC) modifies the association between alcohol consumption and GC risk in the Korean population. ...
Comparison of Surveillance with Low-dose and Contrast-enhanced Chest Computed Tomography in Patients Disease-free for Two Years after Curative Resection for Lung Cancer [0.03%]
低剂量与造影增强胸部计算机断层扫描在肺癌治愈性切除术后两年无病患者监测中的比较研究
Bubse Na,Ji Hyeon Park,Kwon Joong Na et al.
Bubse Na et al.
Purpose: Low-dose chest computed tomography (LDCT) is recommended for surveillance 2-3 years after curative resection of non-small cell lung cancer (NSCLC); however, supporting clinical evidence is limited. This study com...
Seo Yoon Jang,Joowon Jang,Jee-Soo Lee et al.
Seo Yoon Jang et al.
Purpose: While TP53 mutations are well known to be associated with adverse prognosis in hematological diseases, their functional impact remains incompletely understood. This study examines the spectrum of TP53 mutations a...
Joon Beom Park,Su-Jin Cho,Myung-Il Hahm et al.
Joon Beom Park et al.
Purpose: This study analyzed nationwide trends in lung cancer surgery in South Korea over 14 years, focusing on surgical volume, patient demographics, surgical approaches, and outcomes. ...
Gender Disparities in Breast Cancer Survival According to Clinical Treatment Score Post-5 Years (CTS5) Risk Stratification [0.03%]
基于临床治疗评分后5年风险分层的乳腺癌生存性别差异研究
Ke Liu,Zhen-Zhen Lu,Zhen-Yu He et al.
Ke Liu et al.
Purpose: The role of The Clinical Treatment Score post-5 years (CTS5) in male breast cancer (MBC) remains unclear. This study aimed to investigate the characteristics and prognosis of CTS5 between MBC and female breast ca...
Non-Operative Management of Rectal Cancer with Adjuvant Chemotherapy after Chemoradiotherapy (NORMANDY): Prospective Study [0.03%]
术前同步放化疗加序贯保守治疗或手术的随机对照研究(NORMANDY)
Hyebin Lee,Hyung Ook Kim,Jason Joon Bock Lee et al.
Hyebin Lee et al.
Purpose: Non-operative management (NOM) has emerged as a promising organ-preserving strategy for patients with rectal cancer who achieve a clinical complete response (cCR) after neoadjuvant chemoradiotherapy (CRT). Howeve...